4//SEC Filing
ARIAD PHARMACEUTICALS INC 4
Accession 0000884731-17-000026
CIK 0000884731operating
Filed
Feb 6, 7:00 PM ET
Accepted
Feb 7, 4:57 PM ET
Size
5.9 KB
Accession
0000884731-17-000026
Insider Transaction Report
Form 4
Herron Jennifer Lyn
Exec V.P. Chief Comm'l Officer
Transactions
- Award
Restricted Stock Units
2017-02-06+5,291→ 5,291 totalExercise: $0.00→ Common Stock (5,291 underlying)
Footnotes (2)
- [F1]The Restricted Stock Units ("RSUs") vest as to approximately one-third of the shares underlying the RSUs on each anniversary of the grant date; provided, however, that, subject to and effective upon the consummation of the transactions contemplated by that certain Agreement and Plan of Merger between ARIAD, Takeda Pharmaceutical Company Limited, and Kiku Merger Co., Inc., dated January 8, 2017, the RSUs shall be converted into the right to receive a cash amount equal to $24.00 for each share of common stock underlying the RSUs, payable in three annual installments on each anniversary of the grant date, subject to the terms of the award.
- [F2]N/A
Documents
Issuer
ARIAD PHARMACEUTICALS INC
CIK 0000884731
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000884731
Filing Metadata
- Form type
- 4
- Filed
- Feb 6, 7:00 PM ET
- Accepted
- Feb 7, 4:57 PM ET
- Size
- 5.9 KB